The path to transformational leadership.
The Dan O’Keeffe SMFM Leadership Academy is designed to engage MFM subspecialists in a unique professional development experience that frames leadership as the ability to build relationships, cultivate excellence, and sustain energy for productive influence, agency, and motivation to enact positive change.
As a participant, you will engage with your peers and gain critical leadership knowledge and skills for today’s healthcare environment. The registration fee includes both in-person sessions, as well as five web-based sessions.
Session 1: October 8-10, 2021
Session 2: March 18-20, 2022
Where: Ritz-Carlton Hotel, Denver, CO
Course Faculty: Mike Foley, MD; Dan O'Keeffe, MD; and Idahlynn Karre, PhD
Registration Rates: The fee includes both in-person sessions and five web-based sessions; all course materials; as well as breakfast and lunch on both in-person sessions.
Members: $3,235
Non-Members: $4,325
To register and for more information, visit SMFM.org.
Impact of antiepileptic medications and sex hormones on maternal and child outcomes in epilepsy
May 16th 2024Paula Emanuela Voinescu, MD, PhD, director of the Women's Epilepsy Program at Brigham and Women's Hospital, talked about the influence of sex hormones on maternal outcomes in pregnant women with epilepsy treated with antiseizure medication.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Echogenic Mass identified as key predictor for retained products of conception
May 13th 2024Discover how recent findings highlight the significance of echogenic masses in accurately diagnosing post-pregnancy complications, shedding light on effective management strategies and reducing the need for invasive interventions.
Read More
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
Adverse maternal outcomes after uterine conservation in placenta accreta spectrum
May 9th 2024A review of 5 studies reveals a significant 1 in 4 incidence of adverse maternal outcomes following uterine conservation in patients with placenta accreta spectrum, underlining the importance of expert multidisciplinary care.
Read More